dBRWD3 Regulates Tissue Overgrowth and Ectopic Gene Expression Caused by Polycomb Group Mutations

Area of Science:

• Molecular Biology
• Genetics
• Epigenetics

Background:

• Polycomb group (PcG) proteins are crucial for maintaining cell fate by repressing specific genes and ensuring normal cell physiology, including cell cycle regulation.
• Loss of PcG function results in ectopic gene expression, leading to developmental defects and malignant tumors, but the molecular mechanisms of this aberrant expression remain unclear.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying ectopic gene expression in PcG mutant cells.
• To identify factors specifically required for the aberrant activation of PcG-repressed genes and associated tissue overgrowth.

Main Methods:

• Investigated the role of dBRWD3, a negative regulator of HIRA/Yemanuclein (YEM)-mediated histone variant H3.3 deposition, in PcG mutant cells.
• Utilized genetic approaches to assess the impact of dBRWD3 mutations on ectopic gene expression and tissue overgrowth in PcG mutants.
• Examined the YEM-dependent mechanism by which dBRWD3 influences these processes.

Main Results:

• Ectopic gene expression in PcG mutant cells specifically requires dBRWD3.
• Mutations in dBRWD3 suppress both the ectopic gene expression and aberrant tissue overgrowth observed in PcG mutants.
• The suppressive effect of dBRWD3 mutations is mediated through a YEM-dependent mechanism.

Conclusions:

• dBRWD3 is identified as a critical regulator uniquely required for ectopic gene expression and aberrant tissue overgrowth caused by PcG mutations.
• Targeting dBRWD3 offers a potential strategy to counteract the detrimental effects of PcG loss-of-function.
• This study sheds light on the molecular basis of gene dysregulation in the context of epigenetic mutations.